Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase
- PMID: 3603567
- DOI: 10.1016/0041-008x(87)90158-x
Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase
Abstract
Toxic doses of acetylcholinesterase (AChE) inhibitors produce prominent motor symptoms (fasciculations, fibrillations, and body tremors) and muscle fiber necrosis. The severity and quality of motor symptoms and fiber necrosis depend upon the specific AChE inhibitor. To examine the importance of nerve and muscle activity in producing muscle necrosis, we recorded electromyographic activity from normal and acutely denervated rat gastrocnemius muscle following administration of the organophosphorus AChE inhibitors soman and diisopropyl fluorophosphate (DFP). The motor symptoms induced on the denervated side represented activity originating at the nerve terminal while those of the contralateral nondenervated muscle represented the sum of peripheral plus central descending activity. The results indicate that soman and DFP produce different responses. At nonlethal toxic doses, the majority of motor symptoms induced by soman is due to impulses descending from the central nervous system, and a proportion of these symptoms are epileptiform activity. This activity is not generated at spinal levels. In contrast, DFP produces motor symptoms mainly by peripheral action that is dependent on a functioning nerve terminal. At lethal doses, both agents have central and peripheral effects. Different patterns of electrical activity are associated with each of the motor symptoms. We found that muscle fiber necrosis correlates best with peripherally generated high-frequency repetitive discharges.
Similar articles
-
Effects of phenytoin, ketamine, and atropine methyl nitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropylphosphorofluoridate.J Toxicol Environ Health. 1988;24(4):439-49. doi: 10.1080/15287398809531175. J Toxicol Environ Health. 1988. PMID: 3411630
-
An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats.Fundam Appl Toxicol. 1984 Aug;4(4):531-8. doi: 10.1016/0272-0590(84)90042-3. Fundam Appl Toxicol. 1984. PMID: 6479498
-
Biochemical and histochemical alterations following acute soman intoxication in the rat.Toxicol Appl Pharmacol. 1987 Mar 15;87(3):393-402. doi: 10.1016/0041-008x(87)90244-4. Toxicol Appl Pharmacol. 1987. PMID: 3564014
-
HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.Biochem Pharmacol. 1982 Apr 1;31(7):1283-7. doi: 10.1016/0006-2952(82)90017-x. Biochem Pharmacol. 1982. PMID: 7092921
-
On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.Pharmacol Biochem Behav. 1990 Feb;35(2):321-5. doi: 10.1016/0091-3057(90)90163-c. Pharmacol Biochem Behav. 1990. PMID: 2157228
Cited by
-
Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine.Acta Neuropathol. 1991;82(2):134-42. doi: 10.1007/BF00293956. Acta Neuropathol. 1991. PMID: 1927269
-
Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.Neurotoxicology. 2008 Nov;29(6):1037-43. doi: 10.1016/j.neuro.2008.08.001. Epub 2008 Aug 13. Neurotoxicology. 2008. PMID: 18765251 Free PMC article.